As of 1:50pm ET
| +0.12 / +0.23%|
The 7 analysts offering 12-month price forecasts for Emergent BioSolutions Inc have a median target of 55.00, with a high estimate of 60.00 and a low estimate of 49.00. The median estimate represents a +7.44% increase from the last price of 51.19.
The current consensus among 7 polled investment analysts is to Buy stock in Emergent BioSolutions Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.